Brief: Datrix's Tech Company 3rdPlace Awarded EU Funding Of EUR 260,000 For Biomedical Solutions

Datrix SpA

07/04/2022 07:45

April 7 (Reuters) - Datrix SpA  DATR.MI :
    * 3RDPLACE, DATRIX GROUP TECH COMPANY FOCUSED ON BUILDING
ARTIFICIAL INTELLIGENCE MODELS, HAS BEEN  AWARDED EU FUNDING FOR
A HORIZON EUROPE PROJECT THAT AIMS TO DEVELOP LOW-COST,
NON-INVASIVE,  HIGHLY RELIABLE AND ACCURATE PRE-SCREENING
SOLUTIONS FOR USE IN BREAST CANCER
    * VALUE OF FUNDING IS 260,000 EUROS OVER THREE AND A HALF
YEARS
    * AIM OF FUNDING IS TO DEVELOP SOLUTIONS FOR USE IN BREAST
CANCER,
THYROID CANCER AND ISCHEMIA DIAGNOSIS

Further company coverage:  DATR.MI 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))